Encompass Health Corp [EHC] stock prices are up 0.47% to $119.75 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EHC shares have gain 0.28% over the last week, with a monthly amount drifted -1.18%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Encompass Health Corp [NYSE: EHC] stock has seen the most recent analyst activity on October 11, 2024, when KeyBanc Capital Markets initiated its Overweight rating and assigned the stock a price target of $115. Previously, Leerink Partners started tracking the stock with Outperform rating on July 10, 2024, and set its price target to $100. On March 06, 2024, Barclays initiated with a Overweight rating and assigned a price target of $95 on the stock. Barclays started tracking the stock assigning a Equal Weight rating and suggested a price target of $57 on March 14, 2023. UBS initiated its recommendation with a Buy and recommended $98 as its price target on September 24, 2021. Raymond James upgraded its rating to Strong Buy for this stock on August 02, 2021, and upped its price target to $107. In a note dated November 23, 2020, Barclays upgraded an Overweight rating on this stock but restated the target price of $96.
The stock price of Encompass Health Corp [EHC] has been fluctuating between $82.74 and $123.13 over the past year. Currently, Wall Street analysts expect the stock to reach $125 within the next 12 months. Encompass Health Corp [NYSE: EHC] shares were valued at $119.75 at the most recent close of the market. An investor can expect a potential return of 4.38% based on the average EHC price forecast.
Analyzing the EHC fundamentals
The Encompass Health Corp [NYSE:EHC] reported sales of 5.51B for trailing twelve months, representing a surge of 10.59%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.25 and Total Capital is 0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.25.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 118.98 points at the first support level, and at 118.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 120.71, and for the 2nd resistance point, it is at 121.66.
Ratios To Look Out For
It’s worth pointing out that Encompass Health Corp [NYSE:EHC]’s Current Ratio is 1.06. In addition, the Quick Ratio stands at 1.06 and the Cash Ratio stands at 0.11. Considering the valuation of this stock, the price to sales ratio is 2.19, the price to book ratio is 5.60 and price to earnings (TTM) ratio is 24.72.
Transactions by insiders
Recent insider trading involved Tarr Mark J, President & CEO, that happened on May 20 ’25 when 0.12 million shares were sold. Officer, Mark Tarr completed a deal on May 20 ’25 to buy 0.12 million shares. Meanwhile, Chief Medical Officer Charbonneau Elissa Joy sold 4279.0 shares on May 06 ’25.
